5-hydroxy Omeprazole
5-hydroxy Omeprazole structure
|
Common Name | 5-hydroxy Omeprazole | ||
|---|---|---|---|---|
| CAS Number | 92340-57-3 | Molecular Weight | 361.41500 | |
| Density | 1.45g/cm3 | Boiling Point | 656.3ºC at 760mmHg | |
| Molecular Formula | C17H19N3O4S | Melting Point | 144-146ºC | |
| MSDS | Chinese USA | Flash Point | 350.7ºC | |
| Symbol |
GHS07 |
Signal Word | Warning | |
Use of 5-hydroxy Omeprazole5-Hydroxyomeprazole is the major metabolite of Omeprazole (HY-B0113). |
| Name | 5-hydroxy omeprazole |
|---|---|
| Synonym | More Synonyms |
| Description | 5-Hydroxyomeprazole is the major metabolite of Omeprazole (HY-B0113). |
|---|---|
| Related Catalog |
| Density | 1.45g/cm3 |
|---|---|
| Boiling Point | 656.3ºC at 760mmHg |
| Melting Point | 144-146ºC |
| Molecular Formula | C17H19N3O4S |
| Molecular Weight | 361.41500 |
| Flash Point | 350.7ºC |
| Exact Mass | 361.11000 |
| PSA | 116.54000 |
| LogP | 2.94930 |
| Index of Refraction | 1.692 |
| Storage condition | -20°C Freezer, Under Inert Atmosphere |
| Symbol |
GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H315-H319-H335 |
| Precautionary Statements | P261-P305 + P351 + P338 |
| Hazard Codes | Xi |
| Risk Phrases | 36/37/38 |
| Safety Phrases | 26-36 |
| RIDADR | NONH for all modes of transport |
|
Development of an in vitro cytochrome P450 cocktail inhibition assay for assessing the inhibition risk of drugs of abuse.
Toxicol. Lett. 230(1) , 28-35, (2014) Drugs of abuse are not tested for cytochrome P450 (CYP) inhibition potential before distribution. Therefore, a cocktail assay should be developed for testing the inhibition potential for all relevant ... |
|
|
In vitro cytochrome P450 inhibition potential of methylenedioxy-derived designer drugs studied with a two-cocktail approach.
Arch. Toxicol. 90 , 305-18, (2016) In vitro cytochrome P450 (CYP) inhibition assays are common approaches for testing the inhibition potential of drugs for predicting potential interactions. In contrast to marketed medicaments, drugs o... |
|
|
Cytochrome P450 inhibition potential of new psychoactive substances of the tryptamine class.
Toxicol. Lett. 241 , 82-94, (2015) New psychoactive substances (NPS) are not tested for their cytochrome P450 (CYP) inhibition potential before consumption. Therefore, this potential was explored for tryptamine-derived NPS (TDNPS) incl... |
| Hydroxyomeprazole |
| 4-Methoxy-6-[[(5-Methoxy-1H-benziMidazol-2-yl)sulfinyl]Methyl]-5-Methyl-3-pyridineMethanol SodiuM Salt |
| 4-Methoxy-6-[[(5-methoxy-1H-benzimidazol-2-yl)sulfinyl]methyl]-5-methyl-3-pyridinemethanol |
| 2-[(5-HYDROXYMETYL-4-METHOXY-3-METHYL-PYRIDIN-2-YL)-METHYLSULFO]-BENZIMIDAZOLE |
| 5-Hydroxy Omeprazole Sodium Salt |
| HydroxyoMeprazole SodiuM Salt |
| [4-Methoxy-6-[(6-methoxy-1H-benzimidazol-2-yl)sulfinylmethyl]-5-methylpyridin-3-yl]methanol |
| 5-hydroxymethylomeprazole |